Sagefield Capital’s 2seventy bio TSVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-115,889
Closed -$572K 125
2025
Q1
$572K Buy
+115,889
New +$368K 0.07% 87

Other funds holding TSVT

Sagefield Capital's TSVT Position: Q2 2025 in Review

Sagefield Capital sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 115,889 shares — an estimated $572K sold.

Sagefield Capital first reported a position in TSVT in Q1 2025 and held it in 1 quarter. The position peaked at $572K in Q1 2025. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

  • Sagefield Capital reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
  • Sagefield Capital sold 115,889 2seventy bio shares in Q2 2025, an estimated $572K.
  • Sagefield Capital first reported a position in 2seventy bio in Q1 2025 and held it in 1 quarter.
  • Sagefield Capital's 2seventy bio position peaked at $572K in Q1 2025.
  • 2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on Sagefield Capital's 13F filing for Q2 2025, filed 14 Aug 2025.